Well Lead Med Co Ltd (603309) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Well Lead Med Co Ltd (603309) has a cash flow conversion efficiency ratio of 0.065x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥126.26 Million ≈ $18.48 Million USD) by net assets (CN¥1.95 Billion ≈ $284.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 603309 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Well Lead Med Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Well Lead Med Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Well Lead Med Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Well Lead Med Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chun Yuan Steel Industry Co Ltd
TW:2010
|
0.019x |
|
BlackRock MIT II
NYSE:BLE
|
-0.063x |
|
Hangzhou Kaierda Welding Robot Co Ltd
SHG:688255
|
0.025x |
|
Hinova Pharmaceuticals Inc. A
SHG:688302
|
N/A |
|
Lem Holding SA
SW:LEHN
|
0.074x |
|
Zhejiang Jinsheng New Materials Co
SHE:300849
|
0.043x |
|
Guangzhou Jiacheng
SHG:603535
|
0.033x |
|
Altice USA Inc
NYSE:ATUS
|
-0.066x |
Annual Cash Flow Conversion Efficiency for Well Lead Med Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Well Lead Med Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Well Lead Med Co Ltd (603309) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.90 Billion ≈ $278.48 Million |
CN¥306.26 Million ≈ $44.82 Million |
0.161x | +26.59% |
| 2023-12-31 | CN¥1.84 Billion ≈ $268.80 Million |
CN¥233.51 Million ≈ $34.17 Million |
0.127x | -43.45% |
| 2022-12-31 | CN¥1.74 Billion ≈ $254.58 Million |
CN¥391.13 Million ≈ $57.23 Million |
0.225x | +91.04% |
| 2021-12-31 | CN¥1.59 Billion ≈ $232.89 Million |
CN¥187.28 Million ≈ $27.41 Million |
0.118x | -41.07% |
| 2020-12-31 | CN¥1.14 Billion ≈ $167.40 Million |
CN¥228.44 Million ≈ $33.43 Million |
0.200x | +15.76% |
| 2019-12-31 | CN¥1.04 Billion ≈ $151.66 Million |
CN¥178.79 Million ≈ $26.16 Million |
0.173x | +80.42% |
| 2018-12-31 | CN¥940.07 Million ≈ $137.56 Million |
CN¥89.89 Million ≈ $13.15 Million |
0.096x | +15.77% |
| 2017-12-31 | CN¥900.07 Million ≈ $131.71 Million |
CN¥74.34 Million ≈ $10.88 Million |
0.083x | -16.45% |
| 2016-12-31 | CN¥863.31 Million ≈ $126.33 Million |
CN¥85.35 Million ≈ $12.49 Million |
0.099x | -5.51% |
| 2015-12-31 | CN¥778.65 Million ≈ $113.94 Million |
CN¥81.47 Million ≈ $11.92 Million |
0.105x | -63.92% |
| 2014-12-31 | CN¥370.18 Million ≈ $54.17 Million |
CN¥107.34 Million ≈ $15.71 Million |
0.290x | +20.35% |
| 2013-12-31 | CN¥302.37 Million ≈ $44.25 Million |
CN¥72.85 Million ≈ $10.66 Million |
0.241x | -27.81% |
| 2012-12-31 | CN¥249.37 Million ≈ $36.49 Million |
CN¥83.23 Million ≈ $12.18 Million |
0.334x | +46.46% |
| 2011-12-31 | CN¥193.41 Million ≈ $28.30 Million |
CN¥44.08 Million ≈ $6.45 Million |
0.228x | -- |
About Well Lead Med Co Ltd
Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in urology, endourology, anaesthesia, respiratory, hemodialysis, and pain management areas worldwide. It provides urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guid… Read more